Condition
Primary Hyperparathyroidism clinical trials and research
As of November 12, 2026, Find a Trial lists 12 Primary Hyperparathyroidism clinical trials that are recruiting, at sites in 6 countries (most in United States (6), Denmark (2), Sweden (1)). By phase: Phase 4 (2), Phase 2/3 (1). There are also 3 NIH-funded research projects on Primary Hyperparathyroidism, with $1.1 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 12Clinical trials
- 3NIH research projects
- 6Countries
Newest Primary Hyperparathyroidism clinical trials
All recruiting trials (12)
-
Role of LH and hCG in adults being evaluated for endocrine disorders
This study looks at whether levels of luteinizing hormone (LH) and hCG in adults undergoing endocrine evaluation relate to their disease presence and outcomes.
-
NIRAF imaging to help parathyroid removal when preoperative tests don’t locate glands
This trial tests whether using an NIRAF camera during parathyroid surgery helps find and remove abnormal glands in people with primary hyperparathyroidism when prior imaging hasn’t pinpointed them.
-
18F‑Fluorocholine PET/MRI and NeuroEXPLORER PET/CT to locate parathyroid tumors
This trial will test whether 18F‑Fluorocholine PET/MRI and NeuroEXPLORER PET/CT scans can better find overactive or cancerous parathyroid glands in adults scheduled for surgery.
-
Amino acid transporter PET/CT imaging with MET/FET for AATS-related tumors
This project tries PET/CT scans using 11C- or 18F-labeled MET/FET tracers to see if they better find primary or metastatic lesions in adults with amino acid transporter–related tumors such as glioma and primary hyperparathyroidism.
-
Using 18F‑choline PET/CT versus ultrasound and sestamibi to locate diseased parathyroid glands
This trial tests whether 18F‑choline PET/CT can better locate diseased parathyroid glands than ultrasound and sestamibi scans in adults with primary hyperparathyroidism who are scheduled for surgery.
-
Effects of zoledronic acid before parathyroid surgery in patients with primary hyperparathyroidism
This study tests if giving a single dose of zoledronic acid before parathyroid surgery can help improve bone health and overall well-being for people with primary hyperparathyroidism.
-
Understanding genetic causes of neuroendocrine tumors in Mexican patients
This study is trying to find out the genetic changes that cause neuroendocrine tumors in Mexican patients to help develop better treatments.
-
Understanding tumor types in patients with primary hyperparathyroidism
This study is trying to see how often different types of tumors occur in people with primary hyperparathyroidism who are having surgery to remove their parathyroid glands.
-
Observational study on outcomes of parathyroidectomy in primary hyperparathyroidism
This study looks at how surgery for primary hyperparathyroidism affects patients' heart, kidney, and bone health, as well as their quality of life, over several years.
-
Observing the natural history of parathyroid disorders
This study looks at the causes and development of parathyroid disorders, like parathyroid cancer and primary hyperparathyroidism, to see how they affect people of all ages, including during pregnancy.
-
Using calcitonin to enhance SPECT-CT imaging for parathyroid adenoma localization
This study is testing if giving calcitonin to patients with primary hyperparathyroidism before a second SPECT-CT scan can help doctors find parathyroid adenomas that were missed in the first scan.
-
Profiling tumors in patients with parathyroid tumors
This study is testing whether analyzing tumor and blood samples from patients with parathyroid tumors can help identify important genes for better diagnosis and treatment options.
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Investigating how Tau affects the parathyroid gland in older adults with hyperparathyroidism
This study is looking at how certain proteins and vitamin D levels affect the parathyroid glands in older adults with primary hyperparathyroidism, to help us understand better how this condition can lead to problems like weak bones and a higher chance of falling.
-
Understanding cognitive issues in older adults with high parathyroid hormone levels
This study looks at how primary hyperparathyroidism might affect memory and thinking skills in older adults aged 65 and up, helping to show why it's important to diagnose and treat this condition for better brain health and overall quality of life.
-
Understanding parathyroid tumors in primary hyperparathyroidism
This study is looking at the genes and features of parathyroid tumors in people with primary hyperparathyroidism to find clues that can help doctors tell if the problem is in one gland or multiple glands, which could lead to better, more tailored treatments for you.
Related topics
Quick answers
How many Primary Hyperparathyroidism clinical trials are recruiting right now?
12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (6 trials), Denmark (2 trials), Sweden (1 trial), China (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 2, Phase 2/3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.